Shield Therapeutics Names New CFO

MT Newswires · 2d ago
04:32 AM EDT, 07/30/2026 (MT Newswires) -- Shield Therapeutics (STX.L) appointed Michael Jensen as its new chief financial officer, effective Sept. 1. Jensen will join the London-listed pharmaceutical company from regenerative medicine company StimLabs, according to a Thursday release.